Novel organometallic compounds for cancer treatment

Simple item page
dc.contributor.authorZhanbossinova, A.
dc.contributor.authorYespolayeva, S.
dc.contributor.authorKhamitova, G.
dc.contributor.authorNegmetzhanov, B.
dc.contributor.authorAlibek, K.
dc.contributor.authorAdilov, S.
dc.date.accessioned2015-10-28T09:19:19Z
dc.date.available2015-10-28T09:19:19Z
dc.date.issued2013
dc.description.abstractIncorporating indole, resorcinol, and porphyrin derivatives into ferrocene and ruthenium complexes could improve their anticancer activity. These compounds are furnished with functional groups which are expected to induce programmed cell death and show high selectivity to cancer cells. Currently, they are at the stage of in vitro testing for anticancer activity.ru_RU
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/558
dc.language.isoenru_RU
dc.publisherNazarbayev Universityru_RU
dc.subjectfirst research weekru_RU
dc.subjectcancer treatmentru_RU
dc.subjectanticancer activityru_RU
dc.titleNovel organometallic compounds for cancer treatmentru_RU
dc.typeAbstractru_RU

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
novel.pdf
Size:
742.71 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

NU Research Week - I